Thirteen stocks signaled bullish momentum by crossing above their 200-day moving averages, indicating potential strength and upward trend continuation.Read More
Oil prices stayed below $95 as hopes of a US-Iran deal cooled supply concerns, with near-term direction hinging on progress in geopolitical talks and actual restoration of supply flows.Read More
Aurobindo Pharma has announced an ₹800-crore buyback at ₹1,475 per share, with April 17, 2026 set as the record date—meaning investors must buy shares before this date to be eligible.Read More
Going forward, the 24,250–24,300 zone is likely to act as a crucial resistance band. A decisive move above this range could trigger a rally towards 24,750–24,800. On the other hand, failure to break above 24,300 convincingly may lead to renewed selling pressure in the market.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
